Skip to search formSkip to main contentSkip to account menu

Femarelle

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

DT56a

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
"DT56a (Femarelle) Stimulates Gender-Specific Human Cultured Bone Cells In Vitro"
DT56a (Femarelle ® ) found to have SERM-like properties is used for the treatment of menopausal symptoms and osteoporosis. In… 
2011
2011
DT56a (Femarelle), contrary to estradiol-17[beta], has a positive stimulatory effect on human derived female cultured bone cells in hyperglycemic conditions
2011
2011
" DT 56 a ( Femarelle ® / Tofupill ) Stimulates Bone Formation in Female Rats "
Objective: DT56a (Femarelle ® ) is a natural compound for the treatment of menopausal symptoms and osteoporosis. The aim of this… 
2009
2009
DT 56 a ( Femarelle ) , contrary to Estradiol-17 and Diadzein , has a positive stimulatory effect on human derived female cultured bone cells in hyperglycemic conditions .
Introduction: Epidemiologic evidence suggests vitamin D is inversely correlated with blood pressure and with cardiovascular… 
2009
2009
Pharmacological doses of the natural phyto-SERM DT 56 a ( Femarelle ) have no effect on MCF-7 human breast cancer cell-line
2005
2005
"Tofupill (Femarelle ® ) Lacks Peripheral Estrogen-like Actions in the Rat Reproductive Tract"
Objective: The objective of this study was to evaluate the estrogenic effect of phytoestrogens contained in a commercial food… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)